Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV004720203 | SCV005326354 | likely pathogenic | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive | criteria provided, single submitter | clinical testing | This variant is a missense change that results in substitution of threonine at amino acid position 250 with arginine. To our knowledge, the p.Thr250Arg variant is absent from patient databases and the medical literature, as well as large population studies (gnomAD v4.0.0). The p.Thr250 is a conserved residue within the core domain, and the majority of in silico tools predict that the p.Thr250Arg change has a damaging effect. While this novel missense variant has not been reported before, we classify it as a likely pathogenic change. This classification is made in consideration of this individual's clinical findings and the observation that this variant is in trans with a known pathogenic variant. Additional information, such as detection in other individuals or functional characterization, may result in variant re-classification in the future. |